Xuejuan Wang

ORCID: 0000-0003-3648-5874
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • Protease and Inhibitor Mechanisms
  • Metal and Thin Film Mechanics
  • Travel-related health issues
  • Peptidase Inhibition and Analysis
  • Lymphoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers

National Cancer Center
2024

National Clinical Research
2024

Chinese Academy of Medical Sciences & Peking Union Medical College
2024

Yan'an Hospital Affiliated To Kunming Medical University
2022

Kunming Medical University
2022

Yunnan Center for Disease Control And Prevention
2022

Kunming University
2022

Even though postoperative chemotherapy can eliminate residual tumor cells in patients with colorectal cancer (CRC), severe adversity, weakened immunity and drug resistance are still problems. Adjuvant cytokine-induced killer (CIK) cell therapy is an alternative to CRC after surgery. The present study investigated the efficacy of adjuvant CIK combined patients.This retrospective analysis included 137 patients, including 71 who received alone (control group) 66 immunotherapy based on (CIT...

10.1002/cti2.1368 article EN cc-by-nc Clinical & Translational Immunology 2022-01-01
Coming Soon ...